Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals, Inc. Reports First Quarter 2018 Results 5/10/18 Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018 5/1/18 Eagle Pharmaceuticals, Inc. to Present at 43rd Annual Deutsche Bank Health Care Conference 4/30/18 Eagle Pharmaceuticals’ Vasopressin ANDA Accepted for Filing by the FDA 4/16/18 Eagle Pharmaceuticals Announces New Patent for Eagle Biologics 3/27/18 Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2017 Results 2/26/18 Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Year End 2017 Financial Results on February 26, 2018 2/15/18 Eagle Pharmaceuticals, Inc. to Present at 2018 RBC Capital Markets Global Healthcare Conference 2/12/18 Eagle Pharmaceuticals Announces Fifth Orange Book Listed Patent for RYANODEX 2/7/18 Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference 1/2/18 Pagination First page Previous page Page 1 Page 2 Current page 3
